The safety and tolerability of intranasal midazolam in epilepsy

References

• Bell GS, Sander JW. The epidemiology of epilepsy: the size of the problem. Seizure 2002;11(Suppl A):306-14. quiz 315-16
   PubMedGoogle Scholar
• Shorvon SD, Goodridge DM. Longitudinal cohort studies of the prognosis of epilepsy: contribution of the National General Practice Study of Epilepsy and other studies. Brain 2013;136(Pt 11):3497-510
   PubMedGoogle Scholar
• Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010;17(3):348-55
   PubMed Web of Science ®Google Scholar
• Appleton R, Macleod S, Martland T. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev 2008;3
   PubMedGoogle Scholar
• Wolf P. Acute drug administration in epilepsy: a review. CNS Neurosci Ther 2011;17(5):442-8
   PubMed Web of Science ®Google Scholar
• Chiang LM, Wang HS, Shen HH, et al. Rectal diazepam solution is as good as rectal administration of intravenous diazepam in the first-aid cessation of seizures in children with intractable epilepsy. Pediatr Neonatol 2011;52(1):30-3
   PubMedGoogle Scholar
• Anderson GD, Saneto RP. Current oral and non-oral routes of antiepileptic drug delivery. Adv Drug Deliv Rev 2012;64(10):911-18
   PubMed Web of Science ®Google Scholar
• Wermeling DP. Intranasal delivery of antiepileptic medications for treatment of seizures. Neurotherapeutics 2009;6(2):352-8
   PubMed Web of Science ®Google Scholar
• Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ. Midazolam: pharmacology and uses. Anesthesiology 1985;62(3):310-24
   PubMed Web of Science ®Google Scholar
• Stahl SM, Grady MM. Stahl’s essential psychopharmacology: the prescriber’s guide. Cambridge University Press; Cambridge, UK ; New York: 2011
   Google Scholar
• Cabrera LS, Santana AS, Robaina PE, Palacios MS. Paradoxical reaction to midazolam reversed with flumazenil. J Emerg Trauma Shock 2010;3(3):307
   PubMedGoogle Scholar
• Harman F, Hasturk AE, Yaman M, et al. Neuroprotective effects of propofol, thiopental, etomidate, and midazolam in fetal rat brain in ischemia-reperfusion model. Childs Nerv Syst 2012;28(7):1055-62
   PubMed Web of Science ®Google Scholar
• Krutak-Krol H, Domino EF. Comparative effects of diazepam and midazolam on paraoxon toxicity in rats. Toxicol Appl Pharmacol 1985;81(3 Pt 1):545-50
   PubMedGoogle Scholar
• Domino EF. Comparative seizure inducing properties of various cholinesterase inhibitors: antagonism by diazepam and midazolam. Neurotoxicology 1987;8(1):113-22
   PubMedGoogle Scholar
• Shih TM, Duniho SM, Mcdonough JH. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol 2003;188(2):69-80
   PubMedGoogle Scholar
• Connors K, Terndrup TE. Nasal versus oral midazolam for sedation of anxious children undergoing laceration repair. Ann Emerg Med 1994;24(6):1074-9
   PubMedGoogle Scholar
• Malinovsky JM, Lejus C, Servin F, et al. Plasma concentrations of midazolam after i.v., nasal or rectal administration in children. Br J Anaesth 1993;70(6):617-20
   PubMedGoogle Scholar
• Allegaert K. The clinical pharmacology of short acting analgo-sedatives in neonates. Curr Clin Pharmacol 2011;6(4):222-6
   PubMedGoogle Scholar
• Adams P, Gelman S, Reves JG, et al. Midazolam pharmacodynamics and pharmacokinetics during acute hypovolemia. Anesthesiology 1985;63(2):140-6
   PubMedGoogle Scholar
• Fisgin T, Gurer Y, Senbil N, et al. Nasal midazolam effects on childhood acute seizures. J Child Neurol 2000;15(12):833-5
   PubMedGoogle Scholar
• Veldhorst-Janssen NM, Fiddelers AA, Van Der Kuy PH, et al. Pharmacokinetics and tolerability of nasal versus intravenous midazolam in healthy Dutch volunteers: a single-dose, randomized-sequence, open-label, 2-period crossover pilot study. Clin Ther 2011;33(12):2022-8
   PubMedGoogle Scholar
• Antonik LJ, Goldwater DR, Kilpatrick GJ, et al. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics. Anesth Analg 2012;115(2):274-83
   PubMed Web of Science ®Google Scholar
• Fukasawa T, Suzuki A, Otani K. Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines. J Clin Pharm Ther 2007;32(4):333-41
   PubMedGoogle Scholar
• Olkkola KT, Ahonen J. Midazolam and other benzodiazepines. Handb Exp pharmacol 2008(182):335-60
   PubMedGoogle Scholar
• Hyland R, Osborne T, Payne A, et al. In vitro and in vivo glucuronidation of midazolam in humans. Br J Clin Pharmacol 2009;67(4):445-54
   PubMed Web of Science ®Google Scholar
• Thakker A, Shanbag P. A randomized controlled trial of intranasal-midazolam versus intravenous-diazepam for acute childhood seizures. J Neurol 2013;260(2):470-4
   PubMedGoogle Scholar
• Holsti M, Dudley N, Schunk J, et al. Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med 2010;164(8):747-53
   PubMedGoogle Scholar
• Holsti M, Sill BL, Firth SD, et al. Prehospital intranasal midazolam for the treatment of pediatric seizures. Pediatr Emerg Care 2007;23(3):148-53
   PubMedGoogle Scholar
• Kuki I, Kawawaki H, Inoue T, et al. [Study of an efficacy and a pharmacokinetics of intranasal midazolam for status epilepticus on childhood epilepsy]. No To Hattatsu 2010;42(1):34-6
   PubMedGoogle Scholar
• Tang RH, Zhou JB. [A control study on the treatment of acute seizures with midazolam and diazepam in children]. Zhongguo Dang Dai Er Ke Za Zhi 2010;12(7):530-2
   PubMedGoogle Scholar
• Mittal P, Manohar R, Rawat AK. Comparative study of intranasal midazolam and intravenous diazepam sedation for procedures and seizures. Indian J Pediatr 2006;73(11):975-8
   PubMedGoogle Scholar
• Bhattacharyya M, Kalra V, Gulati S. Intranasal midazolam vs rectal diazepam in acute childhood seizures. Pediatr Neurol 2006;34(5):355-9
   PubMed Web of Science ®Google Scholar
• Harbord MG, Kyrkou NE, Kyrkou MR, et al. Use of intranasal midazolam to treat acute seizures in paediatric community settings. J Paediatr Child Health 2004;40(9-10):556-8
   PubMed Web of Science ®Google Scholar
• Mahmoudian T, Zadeh MM. Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children. Epilepsy Behav 2004;5(2):253-5
   PubMed Web of Science ®Google Scholar
• Fisgin T, Gurer Y, Tezic T, et al. Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: prospective randomized study. J Child Neurol 2002;17(2):123-6
   PubMed Web of Science ®Google Scholar
• Scheepers M, Scheepers B, Clarke M, et al. Is intranasal midazolam an effective rescue medication in adolescents and adults with severe epilepsy? Seizure 2000;9(6):417-22
   PubMedGoogle Scholar
• Scheepers M, Scheepers B, Clough P. Midazolam via the intranasal route: an effective rescue medication for severe epilepsy in adults with learning disability. Seizure 1998;7(6):509-12
   PubMedGoogle Scholar
• Lahat E, Goldman M, Barr J, et al. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. BMJ 2000;321(7253):83-6
   PubMed Web of Science ®Google Scholar
• Lahat E, Goldman M, Barr J, et al. Intranasal midazolam for childhood seizures. Lancet 1998;352(9128):620
   PubMedGoogle Scholar
• Jeannet PY, Roulet E, Maeder-Ingvar M, et al. Home and hospital treatment of acute seizures in children with nasal midazolam. Eur J Paediatr Neurol 1999;3(2):73-7
   PubMedGoogle Scholar
• De Haan GJ, Van Der Geest P, Doelman G, et al. A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations. Epilepsia 2010;51(3):478-82
   PubMed Web of Science ®Google Scholar
• O’regan ME, Brown JK, Clarke M. Nasal rather than rectal benzodiazepines in the management of acute childhood seizures? Dev Med Child Neurol 1996;38(11):1037-45
   PubMedGoogle Scholar
• Kutlu NO, Yakinci C, Dogrul M, Durmaz Y. Intranasal midazolam for prolonged convulsive seizures. Brain Dev 2000;22(6):359-61
   PubMedGoogle Scholar
• Kyrkou M, Harbord M, Kyrkou N, et al. Community use of intranasal midazolam for managing prolonged seizures. J Intellect Dev Disabil 2006;31(3):131-8
   PubMed Web of Science ®Google Scholar
• Mula M. Emerging drugs for focal epilepsy. Expert Opin Emerg Drugs 2013;18(1):87-95
   PubMed Web of Science ®Google Scholar
• Bancke L, Dworak H, Halvorsen M. Pharmacokinetics of USL261, a novel formulation of intranasal midazolam (P02.212). Neurology 80; Meeting Abstract 1) 2013
   Google Scholar
• Dworak H, Bancke L, Halvorsen M. Safety and pharmacodynamics of USL261, a novel formulation of midazolam optimized for intranasal administration (P02.211). Neurology 80; Meeting Abstract 1); 2013
   Google Scholar
• Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012;366(7):591-600
   PubMed Web of Science ®Google Scholar
• Appleton R, Sweeney A, Choonara I, et al. Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus. Dev Med Child Neurol 1995;37(8):682-8
   PubMed Web of Science ®Google Scholar